Biostem Technologies Inc (BSEM) financials · P/E 8.5, rev $14.0M
Biostem Technologies Inc (BSEM) P/E 8.5, rev $14.0M.
| Line | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | $14.0M | $26.9M |
| Cost of Revenue | $5.4M | $1.5M |
| Gross Profit | $8.6M | $25.4M |
| Operating Income | -$17.3M | $5.4M |
| Net Income | -$17.8M | $3.9M |
| EPS (Diluted) | $-1.04 | $0.17 |
| Line | Q2 2026 | Q2 2025 |
|---|---|---|
| Total Assets | $48.8M | $50.0M |
| Current Assets | $20.8M | $44.4M |
| Cash & Equivalents | $7.0M | $29.5M |
| Inventory | $4.7M | $2.9M |
| PP&E | $4.4M | $4.0M |
| Total Liabilities | $21.2M | $10.9M |
| Current Liabilities | $21.2M | $10.8M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $27.6M | $39.1M |
| Retained Earnings | -$39.0M | -$21.2M |
| Line | Q2 2026 | Q2 2025 |
|---|---|---|
| Operating Cash Flow | -$6.4M | $9.5M |
| CapEx | $57.9K | $497.1K |
| Investing Cash Flow | -$15.1M | -$497.1K |
| Financing Cash Flow | -$1.1M | -$988.0K |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $0 |
| Free Cash Flow | -$6.4M | $9.0M |
FAQ
What is BSEM P/E and revenue?
Biostem Technologies Inc (BSEM) P/E 8.5, rev $14.0M.
What is BSEM revenue?
Biostem Technologies Inc last cached revenue is $14.0M (Q2 2026).
Is BSEM profitable?
Biostem Technologies Inc last cached net income is -$17.8M.
What are BSEM total assets?
Biostem Technologies Inc last cached total assets are $48.8M.
What is BSEM free cash flow?
Biostem Technologies Inc last cached free cash flow is -$6.4M.
Not investment advice. Cached statements, not a live tape.